Study of Predictors of Failure of Sulprostone Treatment in Postpartum Hemorrhage (NALAPOST)

University Hospital, Strasbourg, France

Status: Completed

Conditions: Postpartum Hemorrhage

Study type: Observational

Funder types: Other

Identifiers

NCT06164236

8013

Details and patient eligibility

About

The investigators wish to identify potential factors predicting failure of second-line drug treatment (sulproston (Nalador®)): risk factors and factors linked to a failure to take initial care for PPH.

A better understanding of the aggravating factors of HPP and more particularly the factors inherent to the initial care would make it possible to think of ways to improve practices.

Enrollment: 300 patients

Sex: Female

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Major subject (≥18 years old)
• Subject having given birth at HUS or CHU Poissy Saint-Germain-en Laye between 01/01/2019 and 31/12/2020
• Subject having presented a postpartum haemorrhage treated with Sulprostone
• Subject not having expressed his opposition, after information, to the reuse of his data for the purposes of this research

Exclusion criteria

• Subject having expressed opposition to participating in the study
• Subject under guardianship or guardianship
• Subject under safeguard of justice